Testing a new bladder-tumor surgery tool for removed tissue
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need surgery at the NIH Clinical Center to remove part or all of your bladder (cystectomy).
- You are a patient of any sex and are age 18 or older.
- Your doctor says you are a good candidate for the planned surgery.
- You can understand the study and sign a consent form.
- You are able and willing to join a related NIH study that collects bladder-related samples (15-C-0087).
- If you are pregnant, you cannot join (pregnancy is excluded).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at urothelial cancer (often bladder cancer) samples taken during diagnosis or standard treatment. It may help researchers better understand the disease by using tissue that doctors already need to collect for care.
This study collects tissue and blood samples from people diagnosed with early-stage bladder cancer (tumors that have not invaded the bladder muscle). The goal is to use these samples for research that could improve future diagnosis and treatment. It may be an opportunity to contribute to medical research.
This study tests a special device that helps remove bladder tumors in one piece during a standard procedure. It aims to make the removal safer and more complete for early-stage bladder cancer.
This trial tests a new robotic system to remove bladder tumors in one piece (en-bloc resection) for people with early-stage, non-muscle invasive bladder cancer. It may offer a more precise surgical option for eligible patients.
This trial tests a new optical probe that gives doctors a clearer view of bladder tumors during cystoscopy. It may help make diagnosis and treatment more accurate.
This clinical trial tests a new drug, BH011, for people with high-risk, non-muscle-invasive bladder cancer that has come back or not responded to BCG therapy. The goal is to see if the drug is safe and works well when given directly into the bladder, as an alternative to bladder removal surgery.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.